Search
Search Results
-
-
Burden of disease attributable to risk factors in European countries: a sco** literature review
ObjectivesWithin the framework of the burden of disease (BoD) approach, disease and injury burden estimates attributable to risk factors are a useful...
-
Conducting national burden of disease studies and knowledge translation in eight small European states: challenges and opportunities
BackgroundSeveral countries across Europe are engaging in burden of disease (BoD) studies. This article aims to understand the experiences of eight...
-
The direct disease burden of COVID-19 in Belgium in 2020 and 2021
BackgroundBurden of disease estimates have become important population health metrics over the past decade to measure losses in health. In Belgium,...
-
Inequalities in the burden of non-communicable diseases across European countries: a systematic analysis of the Global Burden of Disease 2019 study
BackgroundAlthough overall health status in the last decades improved, health inequalities due to non-communicable diseases (NCDs) persist between...
-
Economic burden of Parkinson’s disease and research trends: a bibliometric analysis
BackgroundParkinson’s disease (PD) is a neurodegenerative disorder associated with a range of motor and non-motor symptom leading to progressive...
-
Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019)
BackgroundThe global burden of inflammatory bowel disease (IBD) is reportedly increasing. Methodologies and datasets are routinely updated, allowing...
-
Disease Burden Attributed to Drug use in the Nordic Countries: a Systematic Analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2019
The Nordic countries share similarities in many social and welfare domains, but drug policies have varied over time and between countries. We wanted...
-
The contribution of the exposome to the burden of cardiovascular disease
Large epidemiological and health impact assessment studies at the global scale, such as the Global Burden of Disease project, indicate that chronic...
-
Global incidence, prevalence and disease burden of silicosis: 30 years’ overview and forecasted trends
BackgroundGlobally, silicosis accounts for 90% of all pneumoconiosis cases and is a serious public health issue. It is characterized by progressive...
-
A proposal for further develo** fatigue-related post COVID-19 health states for burden of disease studies
Previous efforts to estimate the burden of fatigue-related symptoms due to long COVID have a very high threshold for inclusion of cases, relative to...
-
Global burden of lower respiratory infections attributable to secondhand smoke among children under 5 years of age, 2010–2019: a systematic analysis of the global burden of disease study 2019
BackgroundEpidemiological trends of lower respiratory infections (LRIs) attributable to secondhand smoke (SHS) among children under 5 years since...
-
“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires
BackgroundInherited epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of skin fragility disorders characterized by...
-
The Multifaceted Burden of Respiratory Syncytial Virus (RSV) Infections in Young Children on the Family: A European Study
IntroductionSince the majority of hospitalisations due to RSV occur in young children, the illness profoundly influences the entire family. However,...
-
Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries
IntroductionRare disease patient data are typically sensitive, present in multiple registries controlled by different custodians, and...
-
The burden and surveillance of RSV disease in young children in Belgium—expert opinion
Infections with respiratory syncytial virus (RSV) can cause severe disease. In young children, RSV is the most common cause of lower respiratory...
-
The Tuscany Regional Network for rare diseases: from European Reference Networks’ experience to registry based organisation and management model for rare diseases
BackgroundIn the European Union, a disease is defined as rare when it affects fewer than 1 in 2000 people. Currently, there are up to 8000 described...
-
Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Sco** Review of Economic Evaluations and Cost-of-Illness Studies
Background and ObjectivesRare diseases have a significant impact on patients, families, the health system, and society. Measuring the socioeconomic...
-
Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan
IntroductionAntimicrobial resistance (AMR) is a major global health threat. While antimicrobial consumption (AMC) in Japan substantially decreased...
-
Develo** a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Sco** Review
Background and ObjectiveRare diseases place a significant burden on patients, families, the healthcare system, and society. Evidence on the...
